US3097202A - 3-[acetonyl; hydroxyethyl; and 2-(4-pyridyl)-ethyl]-1-(5-nitrofurfurylideneamino) hydntoin - Google Patents

3-[acetonyl; hydroxyethyl; and 2-(4-pyridyl)-ethyl]-1-(5-nitrofurfurylideneamino) hydntoin Download PDF

Info

Publication number
US3097202A
US3097202A US78315A US7831560A US3097202A US 3097202 A US3097202 A US 3097202A US 78315 A US78315 A US 78315A US 7831560 A US7831560 A US 7831560A US 3097202 A US3097202 A US 3097202A
Authority
US
United States
Prior art keywords
ethyl
nitrofurfurylideneamino
pyridyl
hydantoin
acetonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US78315A
Other languages
English (en)
Inventor
Michels Julian Getz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott Pharmaceuticals Inc
Original Assignee
Norwich Pharmacal Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1310188D priority Critical patent/FR1310188A/fr
Application filed by Norwich Pharmacal Co filed Critical Norwich Pharmacal Co
Priority to US78315A priority patent/US3097202A/en
Priority to DEN20887A priority patent/DE1147590B/de
Priority to DEN20886A priority patent/DE1147589B/de
Priority to CH1413961A priority patent/CH414651A/de
Priority to GB43775/61A priority patent/GB1002644A/en
Priority to CH667866A priority patent/CH416652A/de
Priority to CH1528665A priority patent/CH411909A/de
Priority to FR882730A priority patent/FR1706M/fr
Priority to SE12807/61A priority patent/SE300107B/xx
Priority to BE611940D priority patent/BE611940A/xx
Priority to BR135262/61A priority patent/BR6135262D0/pt
Priority to ES0273245A priority patent/ES273245A1/es
Priority to NL272956D priority patent/NL272956A/xx
Application granted granted Critical
Publication of US3097202A publication Critical patent/US3097202A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/80Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Definitions

  • This invention relates to 1-(5-nitrofurfurylideneamino) hydantoins substituted in the 3-position of the hydantoin nucleus which may be represented by the formula:
  • R represents a member of the group consisting of acetonyl, hydroxyethyl and 2-(4-pyridy1)ethyl.
  • hydantoins are highly effective, relatively nontoxic systemic antimicrobial agents. They control systemic infections in animals caused by microorganisms such as Staphylococcus aureus and Eimeria tenella. Mice lethally infected with S. aureus are protected by the peroral administration of a single dose of from 105-210 mg./ kg. of these compounds given post infection as a suspension in carboxylmethylcellulose. Chickens infected with E. tenella are protected against the morbidity and mortality associated with coccidiosis provoked by that organism through the administration of these compounds incorporated in their feed at a level of 0.022% by weight.
  • mice tolerable doses of these compounds range from 7702200 mg./kg. In chickens no evidence of toxic side elfect is seen at the level employed to combat coccidiosis.
  • the methods which I have employed for the production of these compounds involve reacting a l-(alkylideneamino)hydantoin or a salt thereof with a compound containing a functional unit to introduce the substituent above defined as R and treating the formed 3-R-substituted-l-(alkylideneamino)hydantoin under hydrolytic conditions if necessary to free the 3-R-substituted-1-aminohydantoin for reaction with 5-nitro-2-furaldehyde or a derivative thereof hydrolyzable thereto.
  • a representative schema In order to convert the I i-substituted-l-(alkylideneamino) hydantoins depicted in the above representative schema (I and II) to the desired S-nitro furfurylidene compound, I have found it to be advantageous to hydrolyze them in an acidified aqueous medium such as aqueous mineral acid under the influence of heat and to add 5- nitrofuraldehyde or an equivalent thereof, such as S-nitrofuraldehyde diacetate which is readily hydrolyzed under the reaction conditions, to the medium. Where the alkylidene component is volatile, steam distillation in the presence of acid is an effective means for removing the volatile component from the reaction mixture and at the same time effecting hydrolysis.
  • 5-nitro-2-furaldehyde diaoetate may be used accompanied by heating to effect its hydrolysis.
US78315A 1960-12-27 1960-12-27 3-[acetonyl; hydroxyethyl; and 2-(4-pyridyl)-ethyl]-1-(5-nitrofurfurylideneamino) hydntoin Expired - Lifetime US3097202A (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
FR1310188D FR1310188A (fi) 1960-12-27
US78315A US3097202A (en) 1960-12-27 1960-12-27 3-[acetonyl; hydroxyethyl; and 2-(4-pyridyl)-ethyl]-1-(5-nitrofurfurylideneamino) hydntoin
DEN20886A DE1147589B (de) 1960-12-27 1961-11-29 Verfahren zur Herstellung von bakterizid wirksamen, in 3-Stellung substituierten Derivaten des 1-(5-Nitrofurfuryliden-amino)-hydantoins
DEN20887A DE1147590B (de) 1960-12-27 1961-11-29 Verfahren zur Herstellung von bakterizid wirksamen, in 3-Stellung substituierten Derivaten des 1-(5-Nitrofurfuryliden-amino)-hydantoins
CH667866A CH416652A (de) 1960-12-27 1961-12-06 Verfahren zur Herstellung von 3-Acetonyl-1-(5-nitrofurfuryliden-amino)-hydantoin
GB43775/61A GB1002644A (en) 1960-12-27 1961-12-06 Improvements in or relating to nitrofurfurylideneamino hydantoins
CH1413961A CH414651A (de) 1960-12-27 1961-12-06 Verfahren zur Herstellung von 3-(2-Hydroxyäthyl)-1-(5-nitro-furfuryliden-amino)-hydantoin
CH1528665A CH411909A (de) 1960-12-27 1961-12-06 Verfahren zur Herstellung eines neuen in 3-Stellung substituierten Derivates des 1-(5-Nitrofurfurylidenamino)-hydantoins
SE12807/61A SE300107B (fi) 1960-12-27 1961-12-21
FR882730A FR1706M (fr) 1960-12-27 1961-12-21 Nouveaux composés antistaphylococciques de la série de l'hydantoine.
BE611940D BE611940A (fi) 1960-12-27 1961-12-22
BR135262/61A BR6135262D0 (pt) 1960-12-27 1961-12-26 Processo para a preparacao de 1-(5-nitrofur-furilideneamino) hidantoinas substituidas na posicao 3 do nucleo hidantoina
ES0273245A ES273245A1 (es) 1960-12-27 1961-12-26 Un metodo de preparar un compuesto representado por la fërmula..
NL272956D NL272956A (fi) 1960-12-27 1961-12-27

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78315A US3097202A (en) 1960-12-27 1960-12-27 3-[acetonyl; hydroxyethyl; and 2-(4-pyridyl)-ethyl]-1-(5-nitrofurfurylideneamino) hydntoin

Publications (1)

Publication Number Publication Date
US3097202A true US3097202A (en) 1963-07-09

Family

ID=22143260

Family Applications (1)

Application Number Title Priority Date Filing Date
US78315A Expired - Lifetime US3097202A (en) 1960-12-27 1960-12-27 3-[acetonyl; hydroxyethyl; and 2-(4-pyridyl)-ethyl]-1-(5-nitrofurfurylideneamino) hydntoin

Country Status (10)

Country Link
US (1) US3097202A (fi)
BE (1) BE611940A (fi)
BR (1) BR6135262D0 (fi)
CH (3) CH416652A (fi)
DE (2) DE1147589B (fi)
ES (1) ES273245A1 (fi)
FR (2) FR1706M (fi)
GB (1) GB1002644A (fi)
NL (1) NL272956A (fi)
SE (1) SE300107B (fi)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3386995A (en) * 1964-06-18 1968-06-04 Norwich Pharma Co 1-substituted-3-(5-nitrofurfurylidene-amino)-2-imidazolidinones
US3446802A (en) * 1960-12-27 1969-05-27 Norwich Pharma Co 3-hydroxymethyl-1-(5-nitrofurfurylideneamino) hydantoin
WO1993004061A1 (en) * 1991-08-14 1993-03-04 Procter & Gamble Pharmaceuticals Novel 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3415821A (en) * 1965-09-07 1968-12-10 Norwich Pharma Co 1-(5-substituted)furfurylideneamino hydantoins and imidazolidinones

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990402A (en) * 1958-10-07 1961-06-27 Smith Kline French Lab Preparation of 1-aminohydantoin derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL253959A (fi) * 1959-11-27

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990402A (en) * 1958-10-07 1961-06-27 Smith Kline French Lab Preparation of 1-aminohydantoin derivatives

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3446802A (en) * 1960-12-27 1969-05-27 Norwich Pharma Co 3-hydroxymethyl-1-(5-nitrofurfurylideneamino) hydantoin
US3386995A (en) * 1964-06-18 1968-06-04 Norwich Pharma Co 1-substituted-3-(5-nitrofurfurylidene-amino)-2-imidazolidinones
WO1993004061A1 (en) * 1991-08-14 1993-03-04 Procter & Gamble Pharmaceuticals Novel 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents

Also Published As

Publication number Publication date
FR1706M (fr) 1963-02-18
BE611940A (fi) 1962-04-16
BR6135262D0 (pt) 1973-05-24
CH414651A (de) 1966-06-15
CH411909A (de) 1966-04-30
DE1147590B (de) 1963-04-25
GB1002644A (en) 1965-08-25
SE300107B (fi) 1968-04-08
CH416652A (de) 1966-07-15
FR1310188A (fi) 1963-03-06
NL272956A (fi) 1964-08-25
DE1147589B (de) 1963-04-25
ES273245A1 (es) 1962-05-01

Similar Documents

Publication Publication Date Title
DE69721526T2 (de) Benzofuran carboxamide und ihre therapeutische anwendung
US4207324A (en) 1,2-Di-Substituted-4-haloimidazole-5-acetic acid derivatives and their use
DE3531487C2 (de) Benzimidazolderivate
AU597696B2 (en) Benzimidazole derivatives
FR2643903A1 (fr) Nouveaux derives de benzimidazole, leurs procedes de preparation, intermediaires de synthese, compositions pharmaceutiques les contenant, utiles notamment pour le traitement des maladies cardiovasculaires, et des ulceres duodenaux
CH624395A5 (fi)
DE3906920A1 (de) Piperazinderivate oder deren salze, verfahren zur herstellung derselben und pharmazeutische mittel mit einem gehalt derselben als wirkstoff
DE3007006C2 (de) Chinoloncarbonsäurederivate, deren Salze, Verfahren zu deren Herstellung und diese Derivate enthaltende Mittel
DE1922003A1 (de) Aminosaeure-Derivate und Verfahren zur Herstellung derselben
EP0096296A2 (de) 1-Sulfo-2-oxoazetidinderivate
JPH0412268B2 (fi)
US3097202A (en) 3-[acetonyl; hydroxyethyl; and 2-(4-pyridyl)-ethyl]-1-(5-nitrofurfurylideneamino) hydntoin
CH641757A5 (en) O-Alkylated hydroxylamines and process for the preparation thereof
CH636099A5 (de) Verfahren zur herstellung von piperidinopropanolderivaten.
DE3927930A1 (de) Cyclisch substituierte (chinolin-2-yl-methoxy)phenyl-essig-saeure-derivate
US3060177A (en) O-(aminoalkyl)oxime derivatives of heterocyclic aldehydes and ketones
DE3739882A1 (de) Substituierte hydroxylamine
NO142647B (no) Fremgangsmaate for fremstilling av smoerbare vann-i-olje-emulsjoner med lavt fettinnhold
DE1164416B (de) Verfahren zur Herstellung von in 3-Stellung aminoalkylierten Derivaten des 1-(5-Nitrofurfuryliden-amino)-hydantoins und ihren Salzen
DE3027106C2 (fi)
CH509318A (de) Verfahren zur Herstellung von substituierten Benzimidazolen
US3001992A (en) S-niteo-z-fubftjewdene
DE3603362A1 (de) In 2-stellung substituierte cycloheptoimidazolverbindungen, ihre herstellung und sie enthaltendes arzneimittel
DE19539091A1 (de) 5-gliedrige Heterocyclen, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zur ihrer Herstellung
US2975185A (en) Piperidinol compounds